Chronic drug-induced liver injury with autoimmune-like features after multiple drug exposures: a case report with serial liver biopsies
This case report describes a patient with chronic drug-induced liver injury exhibiting autoimmune-like features who achieved biochemical remission and histological improvement over time, highlighting the importance of long-term follow-up and repeat liver biopsies to assess persistent histological damage even after biochemical normalization.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
The liver is the body's tireless chemical processing plant, filtering toxins, breaking down nutrients, and managing waste. Sometimes, this vital organ is overwhelmed by medicines or herbal supplements, leading to a condition known as drug-induced liver injury. While most people recover fully once they stop taking the offending substance, a small number of patients develop a lingering problem where the liver continues to attack itself, mimicking a different disease called autoimmune hepatitis. In this scenario, the body's immune system, which usually protects against invaders, mistakenly targets healthy liver cells, causing inflammation and scarring. Distinguishing between a lingering drug reaction and a true autoimmune disease is notoriously difficult because they look almost identical under a microscope and in blood tests. This distinction matters deeply, as the treatment for one might differ from the other, and understanding how long the damage lasts is crucial for a patient's future health.
A team of doctors at Beijing Ditan Hospital recently shared the story of a 41-year-old woman who navigated this complex medical puzzle. The woman began taking a weight-loss supplement and a traditional Chinese medicine preparation on her own. About a month later, she became severely ill, developing extreme fatigue, a loss of appetite, and a yellowing of her skin and eyes. Blood tests revealed that her liver enzymes were dangerously high, and her blood contained high levels of antibodies and a specific protein called IgG, which are often signs that the immune system is overactive. Initially, doctors suspected the supplements were the cause, but the presence of these immune markers raised a red flag for autoimmune hepatitis.
After stopping the supplements, her condition did not improve on its own. Her liver function remained unstable, and her blood tests continued to show signs of immune system aggression. The medical team decided to treat her with steroids, powerful anti-inflammatory medicines that calm the immune system. This approach worked; her blood levels eventually returned to normal, and she was able to stop taking the steroids in early 2024 without her condition flaring up again. However, the doctors faced a lingering question: even though her blood looked healthy, was her liver truly healed?
To answer this, the team performed a liver biopsy, a procedure where a tiny sample of liver tissue is removed and examined under a microscope. They did this for the first time in October 2024, nearly a year after her initial illness and nine months after she stopped the steroids. Surprisingly, despite her blood tests being perfectly normal, the tissue sample told a different story. The liver still showed significant signs of chronic inflammation and advanced scarring, a stage of damage that would typically require ongoing treatment. This finding highlighted a critical disconnect: the visible signs of disease in the blood had vanished, but the hidden damage inside the organ remained.
The doctors did not stop there. They waited another year and a half, monitoring the woman closely. In January 2026, they performed a second biopsy to see if the liver had continued to heal on its own. This time, the results were encouraging. The new tissue sample showed much less inflammation and significantly less scarring than the first one. The damage had improved from a severe level to a mild one, suggesting that the liver was slowly repairing itself long after the initial injury and the steroid treatment had ended.
This case provides a rare and detailed look at how drug-induced liver injury can evolve over time. The woman's experience suggests that she likely suffered from a specific type of drug reaction that triggered autoimmune-like features, rather than a classic, lifelong autoimmune disease. The fact that she remained healthy for nearly two years after stopping all medication supports this conclusion. However, because the exact ingredients of the weight-loss agent and the herbal medicine were unknown, the doctors could not definitively rule out other possibilities, and they emphasize that long-term observation remains necessary.
The most important lesson from this story is that a normal blood test does not always mean a liver is fully healed. In this patient, the blood markers of disease disappeared long before the physical scarring in the liver began to fade. This suggests that for patients who have suffered severe liver damage, relying solely on blood tests might miss ongoing problems. In cases where the initial injury was severe, repeating a biopsy after a long period can reveal whether the organ is truly recovering or if hidden damage persists. While the woman's liver eventually showed signs of improvement, her journey underscores the complexity of liver diseases and the value of looking beyond the surface to understand the full picture of a patient's health.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.